Skip Nav Destination
Issues
Departments
Editorial
Diabetes Treatment Options: One Size Does NOT Fit All
Topics:
health personnel
,
patient care team
,
cardiovascular event
,
diabetes mellitus complications
,
diabetes mellitus, type 2
Clinical Diabetes April 2012, Vol.30, 41-43. doi:https://doi.org/10.2337/diaclin.30.2.41
Bridges to Excellence
Use of A1C for Screening and Diagnosis of Type 2 Diabetes in Three Rural Health Care Systems
Topics:
diabetes mellitus, type 2
,
glucose
,
prediabetes
,
screening
,
rural health
Clinical Diabetes April 2012, Vol.30, 61-66. doi:https://doi.org/10.2337/diaclin.30.2.61
Translating Research to Practice
Postprandial Blood Glucose, Cardiovascular Events, and All-Cause Mortality: How Do We Use Postprandial Glucose in Clinical Practice?
Topics:
blood glucose
,
cardiovascular event
,
glucose
,
postprandial period
,
cardiovascular diseases
Clinical Diabetes April 2012, Vol.30, 67-69. doi:https://doi.org/10.2337/diaclin.30.2.67
Case Studies
A New Challenge for Safe Ordering of U-500 Insulin: Electronic Medicine Reconciliation
Topics:
insulin
Clinical Diabetes April 2012, Vol.30, 70-71. doi:https://doi.org/10.2337/diaclin.30.2.70
Management of Type 2 Diabetes: What Is the Next Step After Metformin?
Topics:
diabetes mellitus, type 2
,
hypoglycemia
,
metformin
,
sulfonylurea compounds
,
weight gain
Clinical Diabetes April 2012, Vol.30, 72-75. doi:https://doi.org/10.2337/diaclin.30.2.72
Diabetes Advocacy
How Proven Primary Prevention Can Stop Diabetes
Topics:
diabetes prevention
,
life style
,
prediabetes
,
primary prevention
,
health personnel
Clinical Diabetes April 2012, Vol.30, 76-79. doi:https://doi.org/10.2337/diaclin.30.2.76
Practical Pointers
Don't Resist Using U-500 Insulin and Pramlintide for Severe Insulin Resistance
Topics:
insulin
,
pramlintide
Clinical Diabetes April 2012, Vol.30, 80-84. doi:https://doi.org/10.2337/diaclin.30.2.80
Patient Inform
Using U-500 Insulin
Topics:
insulin
Clinical Diabetes April 2012, Vol.30, 86. doi:https://doi.org/10.2337/diaclin.30.2.86
Feature Articles
The Ideal Diabetes Therapy: What Will It Look Like? How Close Are We?
Lisa S. Rotenstein, BA; Benjamin M. Kozak, BA; Joseph P. Shivers, BA; Mark Yarchoan, BA; John Close, MBA; Kelly L. Close, MBA
Topics:
antidiabetics
,
exenatide
,
glucagon-like peptide-1 agonists
,
glucose
,
hypoglycemia
Clinical Diabetes April 2012, Vol.30, 44-53. doi:https://doi.org/10.2337/diaclin.30.2.44
A Perspective on Principles of Comparative Cost-Effectiveness Studies for Pharmacotherapy of Chronic Diseases
Topics:
atorvastatin
,
chronic disease
,
pharmacotherapy
,
simvastatin
,
statins
Clinical Diabetes April 2012, Vol.30, 54-60. doi:https://doi.org/10.2337/diaclin.30.2.54